Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Perspective Therapeutics (CATX) Long-Term Investments (2016)

Perspective Therapeutics (CATX) has disclosed Long-Term Investments for 3 consecutive years, with $3.0 million as the latest value for Q2 2016.

  • Quarterly Long-Term Investments fell 41.78% to $3.0 million in Q2 2016 from the year-ago period, while the trailing twelve-month figure was $3.0 million through Jun 2016, down 41.78% year-over-year, with the annual reading at $3.0 million for FY2016, 41.78% down from the prior year.
  • Long-Term Investments hit $3.0 million in Q2 2016 for Perspective Therapeutics, down from $5.2 million in the prior quarter.
  • In the past five years, Long-Term Investments ranged from a high of $5.4 million in Q2 2014 to a low of $3.0 million in Q2 2016.
  • Historically, Long-Term Investments has averaged $4.8 million across 3 years, with a median of $5.2 million in 2015.
  • Biggest five-year swings in Long-Term Investments: fell 5.45% in 2015 and later plummeted 41.78% in 2016.
  • Year by year, Long-Term Investments stood at $5.4 million in 2014, then dropped by 4.4% to $5.2 million in 2015, then tumbled by 42.42% to $3.0 million in 2016.
  • Business Quant data shows Long-Term Investments for CATX at $3.0 million in Q2 2016, $5.2 million in Q1 2016, and $5.2 million in Q4 2015.